43 participants
An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-07-18
- Start Date:
- 2016-10-01
- Completion:
- 2019-05-31
Conditions
- Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Interventions
- DRUG
No Results Yet